Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

Comedian Dave Coulier has drawn attention to tongue cancer diagnosis after recently sharing his health journey. Coulier, known for his role in the beloved sitcom Full House, disclosed that he is battling early-stage P16 carcinoma, a type of oropharyngeal tongue cancer.
The term oropharyngeal refers to cancer that originates at the base of the tongue. The P16 factor indicates an association with human papillomavirus, or HPV. This announcement arrives just months after Coulier’s previous struggle with non-Hodgkin lymphoma, which he confirmed was completely unrelated to his new diagnosis.
During a recent interview, Coulier explained how he discovered the new cancer. He recounted, “I went in for a PET scan, just a routine check-up, and something flared on the PET scan. It turned out that I have P16 squamous carcinoma at the base of my tongue.” Coulier had celebrated being cancer-free just a few months prior.
He revealed, “To go through chemotherapy and feel that relief of whoah, it’s gone, and then to get a test that says, well now you’ve got another kind of cancer … it is a shock to the system.” In response to this diagnosis, Coulier will undergo a rigorous treatment plan involving 35 radiation sessions.
The National Cancer Institute highlights that tongue cancer can affect different areas: the front of the tongue, known as the oral cavity, or the base of the tongue, referred to as the oropharynx. The prognosis can vary widely based on the location of the tumor.
Projections for 2025 indicate around 20,040 new cases of tongue cancer will emerge, with an estimated 3,270 fatalities. Notably, these statistics only pertain to cancers initiating in the anterior two-thirds of the tongue.
When examining all oral cavity and oropharyngeal cancers, which include both mouth and throat cancers, the American Cancer Society estimates new cases will rise to 59,660 with roughly 12,770 expected deaths by 2025.
The overall five-year survival rate for tongue cancer stands at 71 percent. Additionally, reports indicate that tongue cancer incidents have been surging across various demographics recently.
Dr. Marc Siegel, Fox News’ senior medical analyst, attributes much of the increase in cases to HPV’s dramatic rise. He explains, “It can metastasize, but the prognosis is 80 to 90 percent curable if it’s HPV-related.”
Dr. George Semeniuk, a medical oncologist at City of Hope, recognizes tongue cancer as one of the fastest-growing head and neck cancers currently affecting patients.
“Early detection is critical,” Semeniuk emphasized, stressing that recognizing early warning signs can significantly impact the outcome of the disease.
Awareness of tongue cancer warning signs is essential for early detection. Some common symptoms include a persistent sore or ulcer on the tongue, pain during swallowing, and unusual lumps or changes in speech.
Semeniuk advises anyone experiencing symptoms lasting more than two weeks to seek evaluation by a specialist. He states, “Look out for a sore that won’t heal or difficulty swallowing. Show your doctor, ENT or dentist.”
Additional signs include the presence of a lump or thickening on the tongue, red or white patches on the tongue or mouth lining, and persistent pain in the mouth, jaw, or throat. Symptoms like numbness, burning sensations on the tongue, and difficulty chewing or speaking could also indicate an underlying issue.
Furthermore, if the cancer spreads, individuals might notice a lump in their neck from enlarged lymph nodes, ear pain on one side, or stiffness and swelling of the jaw.
The primary risk factors for developing tongue cancer encompass tobacco use, heavy alcohol consumption, and HPV. Semeniuk noted a worrying trend: increasing numbers of younger adults who have never smoked are now receiving diagnoses, underscoring HPV’s significant role in the disease’s rise.
Other contributing factors include chronic mouth irritation, weakened immune systems, and poor oral hygiene, which may elevate the risk of tongue cancer.
Tongue cancer treatment primarily hinges on the disease’s stage and tumor location. Experts stress that it often involves a combination of surgery, radiation therapy, and potentially chemotherapy or targeted therapies in advanced cases.
Dr. Semeniuk pointed out that at City of Hope, they use minimally invasive surgical techniques and precision-guided therapies to preserve vital functions like speech and swallowing whenever feasible.
According to Siegel, tumors associated with tongue cancer tend to respond well to surgical resection, radiation, and chemotherapeutic approaches. Early diagnosis significantly enhances prognosis. For patients identified in the early stages, cure rates can be remarkably high.
The importance of routine dental visits and HPV vaccinations cannot be overstated. Such preventive measures play crucial roles in reducing the risk of tongue cancer and enhancing individuals’ overall oral health. Both the medical community and patients must remain vigilant and proactive in detecting early signs of tongue cancer.